• Molecular NameSufentanil
  • Synonymsufentanil; Sufentanil Citrate; Sufentanilum [INN-Latin]; Sufentanyl; Sulfentanil Citrate
  • Weight386.56
  • Drugbank_IDDB00708
  • ACS_NO56030-54-7
  • Show 3D model
  • LogP (experiment)3.95
  • LogP (predicted, AB/LogP v2.0)4.15
  • pkaN/A
  • LogD (pH=7, predicted)2.93
  • Solubility (experiment)0.076 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.59
  • LogSw (predicted, AB/LogsW2.0)0.13
  • Sw (mg/ml) (predicted, ACD/Labs)0.22
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds8
  • TPSA61.02
  • StatusFDA approved
  • AdministrationInjection
  • PharmacologyA powerful synthetic opioid analgesic drug, approximately 5 to 10 times more potent than its analog, Fentanyl.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding93.0
  • Volume of distribution (VD)2.9 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life265 min
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=18.7 mg/kg (IV)